Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
EpiVario Logo
EpiVario Growth Score
84
CB Rank
60913
Heat Score
69
EpiVario develops novel compounds to treat memory-related psychiatric disorders at the source of the disease.
Founded
obfuscation
PrivateGrant Philadelphia, Pennsylvania, United States1-10 epivario.com/
Biopharma
Biotechnology
Pharmaceutical
Overview

EpiVario
Total Funding
obfuscation
Growth Score
84
Heat Score
69

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score84
-5 pts
in past quarter
Heat Score 69
-1 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About EpiVario

CB Rank
60913
EpiVario develops novel compounds to treat memory-related psychiatric disorders at the source of the disease.
Founded
obfuscation
PrivateGrant Philadelphia, Pennsylvania, United States1-10 epivario.com/
Biopharma
Biotechnology
Pharmaceutical

Funding Rounds

Grant
OBF
in
obfuscation
Grant
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

Details

Legal Name EpiVario Inc.
Operating Status Active
Company Type For Profit
Founders  Philipp Mews, Shelley Berger
About the Company
EpiVario is a preclinical pharmaceutical company that develops novel compounds for the goal of reducing or preventing the pathogenesis of psychiatric diseases: post-traumatic stress disorder (PTSD) and substance abuse disorders. EpiVario was founded in 2017 and is based in Philadelphia, Pennsylvania.
Phone Number (215) 400.0133
Diversity Spotlight 
Women Founded
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

ACSS2 Inhibitor
A proprietary small molecule inhibitor targeting the ACSS2 enzyme to modulate epigenetic processes controlling neuronal plasticity and long-term memory formation.
Neuroepigenetic Modulators
Compounds developed to treat memory-related addiction and psychiatric disorders by targeting epigenetic processes in long-term memory.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - EpiVario Logo
Grant - EpiVario
1
obfuscation
National Institute on Drug Abuse (NIDA)Grant
obfuscation
Grant - EpiVario Logo
Grant - EpiVario
1
obfuscation
National Institute on Drug Abuse (NIDA)Grant
obfuscation
Grant - EpiVario Logo
Grant - EpiVario
1
obfuscation
National Institute on Drug Abuse (NIDA)Grant
obfuscation
Grant - EpiVario Logo
Grant - EpiVario
1
obfuscation
National Institute on Drug Abuse (NIDA)Grant
obfuscation
Grant - EpiVario Logo
Grant - EpiVario
1
obfuscation
National Institute on Drug Abuse (NIDA)Grant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 4
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - EpiVario Logo
Grant - EpiVario
1
obfuscation
National Institute on Drug Abuse (NIDA)Grant
obfuscation
Grant - EpiVario Logo
Grant - EpiVario
1
obfuscation
National Institute on Drug Abuse (NIDA)Grant
obfuscation
Grant - EpiVario Logo
Grant - EpiVario
1
obfuscation
National Institute on Drug Abuse (NIDA)Grant
obfuscation
Grant - EpiVario Logo
Grant - EpiVario
1
obfuscation
National Institute on Drug Abuse (NIDA)Grant
obfuscation
Grant - EpiVario Logo
Grant - EpiVario
1
obfuscation
National Institute on Drug Abuse (NIDA)Grant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
National Institute on Drug Abuse (NIDA) Logo
National Institute on Drug Abuse (NIDA)
Yes
Grant - EpiVario Logo
Grant - EpiVario
—
National Institute on Drug Abuse (NIDA) Logo
National Institute on Drug Abuse (NIDA)
Yes
Grant - EpiVario Logo
Grant - EpiVario
—
National Institute on Drug Abuse (NIDA) Logo
National Institute on Drug Abuse (NIDA)
Yes
Grant - EpiVario Logo
Grant - EpiVario
—
National Institute on Drug Abuse (NIDA) Logo
National Institute on Drug Abuse (NIDA)
Yes
Grant - EpiVario Logo
Grant - EpiVario
—
National Institute on Drug Abuse (NIDA) Logo
National Institute on Drug Abuse (NIDA)
Yes
Grant - EpiVario Logo
Grant - EpiVario
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2 Contacts 2

Employee Profiles

News

News and Press

News•Jan 16, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 11, 2022
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 16, 2021
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 23, 2019
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

845
186.44%
 in past month

IT Spend

$18KThis year, EpiVario is projected to spend $18K on IT, according to Aberdeen.

Active Website Tech Count

2EpiVario is actively using 2 technologies for its website, according to BuiltWith. These include Viewport Meta and  CommonCrawl Top 50m.

Total IP

3The intellectual property of EpiVario includes 3 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is EpiVario's headquarters? EpiVario is located in Philadelphia, Pennsylvania, United States.Who invested in EpiVario? EpiVario has 2 investors including National Institute on Drug Abuse (NIDA) and  National Institute on Drug Abuse (NIDA).When was the last funding round for EpiVario? EpiVario closed its last funding round on
obfuscation
from a Grant round.Who are EpiVario's competitors? Alternatives and possible competitors to EpiVario may include Vertex Pharmaceuticals, COMPASS Pathways, and  Aquestive Therapeutics.How much funding has EpiVario raised to date? EpiVario has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5d46e5f 1)
|